Pherecydes Pharma discloses its upcoming Governance Structure with Guy-Charles Fanneau de la Horie as CEO alongside Didier Hoch as Chairman of the Board of Directors
– FRANCE, Nantes – Pherecydes Pharma (EPA: ALPHE), a biotechnology company specializing in precision phage therapy, today announced the change in its governance structure by adopting a Board of Directors instead of the existing Supervisory Board and Executive Board.…